GSK meningitis vaccine Nimenrix gets European approval

A new bacterial meningitis vaccine from GlaxoSmithKline (NYSE:GSK) now has European approval. Nimenrix was granted marketing authorization for immunization against meningitis caused by bacteria called…
Read the full story: MedCity News